Valuation: Veeva Systems Inc.

Market Cap 45.89B 40.94B 38.14B 34.71B 65.37B 4,420B 65.85B 461B 179B 2,256B 172B 169B 7,251B P/E 2027 *
43.4x
P/E 2028 * 38.8x
Enterprise Value 38.84B 34.65B 32.28B 29.37B 55.32B 3,740B 55.73B 390B 152B 1,909B 146B 143B 6,136B EV / Sales 2027 *
10.5x
EV / Sales 2028 * 9.13x
Free-Float
91.38%
Yield 2027 *
-
Yield 2028 * -
1 week+2.11%
Current month+0.12%
1 month+6.75%
3 months+50.12%
6 months+67.34%
Current year+32.11%
1 week 241.8
Extreme 241.8
258.2
1 month 222.4
Extreme 222.4
258.2
3 years 127.45
Extreme 127.45
263.1
5 years 127.45
Extreme 127.45
281.7
10 years 32.93
Extreme 32.932
287.1
Manager TitleAgeSince
Chief Executive Officer 61 2007-01-11
Director of Finance/CFO 44 2024-09-15
President 56 2024-03-31
Director TitleAgeSince
Director/Board Member 61 2011-08-03
Director/Board Member 53 2019-12-31
Chairman 61 2008-07-31
Change 5-day change 1-year change 3-year change Capi.($)
+3.92%-1.78%-0.24%+33.37% 44.25B
+3.35%-0.27%+24.56%+35.89% 242B
+3.34%-2.69%+2.89%+2.00% 150B
+3.71%-2.00%-10.14%+40.12% 138B
-0.47%-3.88%-56.43%-17.96% 61.74B
+2.44%+0.46%+13.18%+20.82% 49.08B
-1.08%-3.15%-21.39%-21.55% 47.43B
+2.09%-2.24%+20.93%+55.22% 47.3B
+3.70%+1.25%-4.33%+40.74% 44.25B
+3.51%-0.64%+34.02%+65.46% 41.78B
Average +2.29%-2.32%+0.31%+25.41% 91.4B
Weighted average by Cap. +2.77%-2.78%+3.85%+25.45%

Financials

2027 *2028 *
Net sales 3.69B 3.29B 3.07B 2.79B 5.26B 355B 5.29B 37.06B 14.42B 181B 13.85B 13.55B 583B 4.14B 3.7B 3.44B 3.13B 5.9B 399B 5.94B 41.6B 16.18B 204B 15.55B 15.21B 654B
Net income 1.08B 962M 896M 816M 1.54B 104B 1.55B 10.83B 4.21B 53.01B 4.05B 3.96B 170B 1.21B 1.08B 1.01B 917M 1.73B 117B 1.74B 12.18B 4.74B 59.6B 4.55B 4.45B 192B
Net Debt -7.06B -6.29B -5.86B -5.34B -10.05B -680B -10.12B -70.86B -27.57B -347B -26.49B -25.92B -1,115B -8.08B -7.21B -6.72B -6.11B -11.52B -779B -11.6B -81.19B -31.59B -397B -30.35B -29.7B -1,277B
Logo Veeva Systems Inc.
Veeva Systems Inc. specializes in the development and marketing of cloud-based solutions for the life sciences industry. The company offers software, data, and consulting services. Its solutions are designed for pharmaceutical and biotechnology companies, as well as companies operating in the technology and medical device sectors. Net sales break down by activity as follows: - subscription sales (84%); - services (16%). Net sales are distributed geographically as follows: North America (59.6%), Europe (29.4%), Asia/Pacific (8.8%) and other (2.2%).
Employees
-
Date Price Change
26-10-05 €251.60 +3.92%
26-10-02 €242.10 -3.35%
26-10-01 €250.50 -0.32%
26-09-30 €251.30 +2.49%
26-09-29 €245.20 -0.49%
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
283.45USD
Average target price
297.30USD
Spread / Average Target
+4.88%

Quarterly revenue - Rate of surprise